Potential neurotoxicity of titanium implants: Prospective, in-vivo and in-vitro study

Titanium dioxide (TiO2) is a frequently used biomaterial, particularly in orthopedic and dental implants, and it is considered an inert and benign compound. This has resulted in toxicological scrutiny for TiO2 in the past decade, with numerus studies showing potential pathologic downstream effects....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomaterials 2021-09, Vol.276, p.121039, Article 121039
Hauptverfasser: Shelly, Shahar, Liraz Zaltsman, Sigal, Ben-Gal, Ofir, Dayan, Avraham, Ganmore, Ithamar, Shemesh, Chen, Atrakchi, Dana, Garra, Sharif, Ravid, Orly, Rand, Daniel, Israelov, Hila, Alon, Tayir, Lichtenstein, Gabriel, Sharabi, Shirley, Last, David, Gosselet, Fabien, Rosen, Vasiliy, Burstein, Gideon, Friedlander, Alon, Harel, Ran, Vogel, Guy, Schnaider Beeri, Michal, Mardor, Yael, Lampl, Yair, Fleminger, Gideon, Cooper, Itzik
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Titanium dioxide (TiO2) is a frequently used biomaterial, particularly in orthopedic and dental implants, and it is considered an inert and benign compound. This has resulted in toxicological scrutiny for TiO2 in the past decade, with numerus studies showing potential pathologic downstream effects. Herein we describe case report of a 77-year-old male with subacute CNS dysfunction, secondary to breakdown of a titanium-based carotid stent and leading to blood levels 1000 times higher (3 ppm) than the reported normal. We prospectively collected tissues adjacent to orthopedic implants and found a positive correlation between titanium concentration and time of implant in the body (r = 0.67, p 
ISSN:0142-9612
1878-5905
DOI:10.1016/j.biomaterials.2021.121039